Tag: legend biotech

$The STORM trial: treatment refractory multiple myeloma patients experience response with selinexor$

Johnson & Johnson and Legend Biotech’s Carvykti shows improved survival in treatment-experienced multiple myeloma patients

byPhilip Heand1 others

July 19, 2024

As a 2nd line therapy for multiple myeloma, Carvykti can lower the risk of disease progression or death by 59% ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Single-dose CRISPR therapy reduces hereditary angioedema attacks
Once-weekly oral islatravir-lenacapavir is noninferior to daily HIV therapy
Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

No Result

View All Result